Clients appreciate that the first step happens quickly and professionally
Clinical trials show GLP-1 receptor agonists reduce waist circumference by approximately 13.5 cm with semaglutide after 68 weeks, with imaging studies demonstrating significant decreases in visceral adipose tissue volume
Severe multisystem symptoms require specialist evaluation Seizures, metabolic strokes, severe weakness, cardiomyopathy, developmental regression, exercise-induced rhabdomyolysis, lactic acidosis, major hearing or vision loss and strong maternal inheritance patterns may require neurological, metabolic or genetic evaluation
That gap in knowledge leads to: Over 1 million ER visits each year due to adverse drug reactions More than 100,000 deaths annually the 4th leading cause of death in the U.S
Thus, combined use of these diagnostic tools will be powerful to characterize bioenergetic phenotypes of PCa tumors and determine treatment options
Don't do it